Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine Concentrations in RIFPB for Postoperative Analgesia After Laparoscopic Cholecystectomy
NCT07841951Not yet recruiting
- Sponsor
- Istanbul Medipol University
- Start
- Jan 2027
- Primary completion
- May 2027
- Countries
- 1
01
Overview
Randomised, double-blind trial of bupivacaine in postoperative pain (3 arms), sponsored by Istanbul Medipol University. Primary endpoint: Total rescue tramadol consumption during the first 24 postoperative hours. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07841951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07841951.